Share-Based Compensation (Details) (USD $)	9 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 56,749,000	$ 54,328,000
Total unrecognized compensation cost related to share-based compensation arrangements	$ 81,000,000
Weighted average period of time for unrecognized compensation cost to be recognized (in years)	2 years 6 months 7 days
Employees' Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options vested, shares	1,144,675
Equity instruments other than options vested, weighted average grant date fair value per share (in USD per share)	$ 4.63
2007 Stock Incentive Plan Amendment [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted, shares	6,212,716
Weighted average fair value of options granted in period (in USD per share)	$ 3.20
Director Restricted Award [Member] | 2009 Non-Employee Directors Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options granted, shares	48,069
Equity instruments other than options granted, weighted average grant date fair value per share (in USD per share)	$ 29.96
Elected Shares [Member] | 2009 Non-Employee Directors Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum percentage of annual director fees that can be received in common stock	100.00%
Matching percentage of shares received in the stock election	50.00%
Equity instruments other than options vested, shares	26,702
Equity instruments other than options vested, weighted average grant date fair value per share (in USD per share)	$ 30.38
Restricted Stock Units [Member] | 2007 Stock Incentive Plan Amendment [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options granted, shares	1,688,848
Equity instruments other than options granted, weighted average grant date fair value per share (in USD per share)	$ 29.65